keyword
https://read.qxmd.com/read/38650929/ferroptosis-in-liver-cancer-a-key-role-of-post-translational-modifications
#21
REVIEW
Ying Xu, Zhiyao Xing, Ruaa Abdalla Ibrahim Suliman, Zichuan Liu, Fengyuan Tang
Ferroptosis is an emerging form of regulated cell death in an oxidative stress- and iron-dependent manner, primarily induced by the over-production of reactive oxygen species (ROS). Manipulation of ferroptosis has been considered a promising therapeutic approach to inhibit liver tumor growth. Nevertheless, the development of resistance to ferroptosis in liver cancer poses a significant challenge in cancer treatment. Post-translational modifications (PTMs) are crucial enzymatic catalytic reactions that covalently regulate protein conformation, stability and cellular activities...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650890/entry-inhibitors-as-arenavirus-antivirals
#22
REVIEW
Kruthika Iyer, Zhonghao Yan, Susan R Ross
Arenaviruses belonging to the Arenaviridae family, genus mammarenavirus, are enveloped, single-stranded RNA viruses primarily found in rodent species, that cause severe hemorrhagic fever in humans. With high mortality rates and limited treatment options, the search for effective antivirals is imperative. Current treatments, notably ribavirin and other nucleoside inhibitors, are only partially effective and have significant side effects. The high lethality and lack of treatment, coupled with the absence of vaccines for all but Junín virus, has led to the classification of these viruses as Category A pathogens by the Centers for Disease Control (CDC)...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38650626/progress-of-medicinal-plants-and-their-active-metabolites-in-ischemia-reperfusion-injury-of-stroke-a-novel-therapeutic-strategy-based-on-regulation-of-crosstalk-between-mitophagy-and-ferroptosis
#23
REVIEW
Guozhen Zhang, Qiang Wang, Bing Jiang, Lihe Yao, Wenjuan Wu, Xiaoyan Zhang, Dongjun Wan, Youquan Gu
The death of cells can occur through various pathways, including apoptosis, necroptosis, mitophagy, pyroptosis, endoplasmic reticulum stress, oxidative stress, ferroptosis, cuproptosis, and disulfide-driven necrosis. Increasing evidence suggests that mitophagy and ferroptosis play crucial regulatory roles in the development of stroke. In recent years, the incidence of stroke has been gradually increasing, posing a significant threat to human health. Hemorrhagic stroke accounts for only 15% of all strokes, while ischemic stroke is the predominant type, representing 85% of all stroke cases...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38650620/use-of-botulinum-toxin-in-the-management-of-dystonia-in-parkinson-s-disease
#24
REVIEW
Charenya Anandan, Joseph Jankovic
Botulinum toxin is one of the most potent neurotoxins, but when injected into an overactive muscle, it can transiently alleviate an involuntary movement, such as dystonia. The primary aim of this article is to provide a comprehensive review of the various forms of dystonia observed in patients with Parkinson's disease who can benefit from a therapeutic trial of botulinum toxin. Although most of these indications are not supported by randomized controlled clinical trials and, therefore, not approved by the Food and Drug Administration, there are many open-label trials supporting a large body of empirical experience testifying to the benefits of botulinum toxin treatment in these conditions...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38650383/current-strategies-for-targeting-hpk1-in-cancer-and-the-barriers-to-preclinical-progress
#25
JOURNAL ARTICLE
Hui Chen, Xiangna Guan, Chi He, Tingting Lu, Xingyu Lin, Xuebin Liao
INTRODUCTION: Hematopoietic progenitor kinase 1 (HPK1), a 97-kDa serine/threonine Ste20-related protein kinase, functions as an intracellular negative regulator, primarily in hematopoietic lineage cells, where it regulates T cells, B cells, dendritic cells and other immune cells. Loss of HPK1 kinase activity results in exacerbated cytokine secretion, enhanced T cell signaling, improved viral clearance, and thus increased restraint of tumor growth. These findings highlight HPK1 as a promising target for immuno-oncology treatments, culminating in the advancement of candidate compounds targeting HPK1 to clinical trials by several biotech enterprises...
April 22, 2024: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/38650382/efficacy-of-collagenase-clostridium-histolyticum-combination-therapies-for-peyronie-s-disease-a-systematic-review-and-meta-analysis
#26
JOURNAL ARTICLE
Yicheng Guo, Yingying Yang, Qiancheng Mao, Hongquan Liu, Tianqi Wang, Fengze Sun, Jitao Wu, Yuanshan Cui
INTRODUCTION: Peyronie's disease (PD) is a common penile disorder characterized by the formation of fibrous noncompliant hard nodules in the tunica albuginea of the penis. Collagenase Clostridium histolyticum (CCH) is an injectable drug that treats PD by enzymatically degrading plaque interstitial collagen. CCH has been used in patients with varying curvature, as well as in the acute and stable phases of the disease, through a variety of treatment regimens and combinations. We carried out a systematic review and meta-analysis to assess the efficacy of CCH combination therapies for PD...
April 22, 2024: Sexual Medicine Reviews
https://read.qxmd.com/read/38649998/dengue-virus-pathogenesis-and-host-molecular-machineries
#27
REVIEW
Saumya Sinha, Kinjal Singh, Y S Ravi Kumar, Riya Roy, Sushant Phadnis, Varsha Meena, Sankar Bhattacharyya, Bhupendra Verma
Dengue viruses (DENV) are positive-stranded RNA viruses belonging to the Flaviviridae family. DENV is the causative agent of dengue, the most rapidly spreading viral disease transmitted by mosquitoes. Each year, millions of people contract the virus through bites from infected female mosquitoes of the Aedes species. In the majority of individuals, the infection is asymptomatic, and the immune system successfully manages to control virus replication within a few days. Symptomatic individuals may present with a mild fever (Dengue fever or DF) that may or may not progress to a more critical disease termed Dengue hemorrhagic fever (DHF) or the fatal Dengue shock syndrome (DSS)...
April 22, 2024: Journal of Biomedical Science
https://read.qxmd.com/read/38649959/artificial-intelligence-and-medical-education-application-in-classroom-instruction-and-student-assessment-using-a-pharmacology-therapeutics-case-study
#28
JOURNAL ARTICLE
Kannan Sridharan, Reginald P Sequeira
BACKGROUND: Artificial intelligence (AI) tools are designed to create or generate content from their trained parameters using an online conversational interface. AI has opened new avenues in redefining the role boundaries of teachers and learners and has the potential to impact the teaching-learning process. METHODS: In this descriptive proof-of- concept cross-sectional study we have explored the application of three generative AI tools on drug treatment of hypertension theme to generate: (1) specific learning outcomes (SLOs); (2) test items (MCQs- A type and case cluster; SAQs; OSPE); (3) test standard-setting parameters for medical students...
April 22, 2024: BMC Medical Education
https://read.qxmd.com/read/38649939/contrast-induced-acute-kidney-injury-a-review-of-definition-pathogenesis-risk-factors-prevention-and-treatment
#29
REVIEW
Yanyan Li, Junda Wang
Contrast-induced acute kidney injury (CI-AKI) has become the third leading cause of hospital-acquired AKI, which seriously threatens the health of patients. To date, the precise pathogenesis of CI-AKI has remained not clear and may be related to the direct cytotoxicity, hypoxia and ischemia of medulla, and oxidative stress caused by iodine contrast medium, which have diverse physicochemical properties, including cytotoxicity, permeability and viscosity. The latest research shows that microRNAs (miRNAs) are also involved in apoptosis, pyroptosis, and autophagy which caused by iodine contrast medium (ICM), which may be implicated in the pathogenesis of CI-AKI...
April 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38649655/perspectives-for-the-clinical-application-of-ctdna-analysis-to-breast-cancer-drug-therapy
#30
JOURNAL ARTICLE
Tetsuhiro Yoshinami
Circulating tumor DNA (ctDNA) consists of DNA fragments released from cancer cells into the blood circulation with quick clearance. Analysis of ctDNA can enable real-time assessment of the presence of cancer cells and their genomic characteristics. Therefore, ctDNA is expected to be one of the most useful biomarkers for cancer. In recent years, several ultra-sensitive assays for ctDNA analysis have been developed, and many clinical trials are using these assays to investigate the efficacy of ctDNA-based therapeutic strategies...
April 23, 2024: Breast Cancer: the Journal of the Japanese Breast Cancer Society
https://read.qxmd.com/read/38649498/-current-developments-in-the-treatment-of-neuroendocrine-tumors
#31
REVIEW
Barbara Kiesewetter-Wiederkehr, Philipp Melhorn, Christian Scheuba, Markus Raderer
BACKGROUND: Well-differentiated neuroendocrine tumors (NET) are rare malignancies that are clinically very heterogeneous. Accordingly, their treatment is also complex and dependent on various factors. With currently available systemic therapies, the prognosis is often favorable. OBJECTIVES: This article aims to provide an overview of current treatment strategies for NET, addressing the most important NET locations. METHODS: The current European guidelines and further relevant literature on the treatment of NET were reviewed for this purpose...
April 22, 2024: Radiologie (Heidelb)
https://read.qxmd.com/read/38649220/toxin-induced-liver-injury-and-extracorporeal-treatment-of-liver-failure
#32
REVIEW
Angela H Lam, Joshua D King
Poisoning with a large variety of drugs and naturally occurring toxins may result in acute liver injury and failure. Drug-induced liver injury is a major cause of liver failure nationwide, and it is likely that nephrologists will be involved in treating patients with these conditions. A number of xenobiotics resulting in liver toxicity may cause acute kidney injury or other organ injury as well. Most agents causing drug- or toxin-induced liver failure lack specific therapies, although a few xenobiotics such as acetaminophen have effective antidotal therapies if administered prior to development of hepatotoxicity...
March 2024: Adv Kidney Dis Health
https://read.qxmd.com/read/38649107/unveiling-cancer-dormancy-intrinsic-mechanisms-and-extrinsic-forces
#33
REVIEW
Ruihua Liu, Yawei Zhao, Shang Su, Augustine Kwabil, Prisca Chinonso Njoku, Haiquan Yu, Xiaohong Li
Tumor cells disseminate in various distant organs at early stages of cancer progression. These disseminated tumor cells (DTCs) can stay dormant/quiescent without causing patient symptoms for years or decades. These dormant tumor cells survive despite curative treatments by entering growth arrest, escaping immune surveillance, and/or developing drug resistance. However, these dormant cells can reactivate to proliferate, causing metastatic progression and/or relapse, posing a threat to patients' survival. It's unclear how cancer cells maintain dormancy and what triggers their reactivation...
April 20, 2024: Cancer Letters
https://read.qxmd.com/read/38648728/research-strategies-of-small-molecules-as-chemotherapeutics-to-overcome-multiple-myeloma-resistance
#34
REVIEW
Jin Yang, Yan-Cheng Yu, Zi-Xuan Wang, Qing-Qing Li, Ning Ding, Xue-Jiao Leng, Jiao Cai, Meng-Yuan Zhang, Jing-Jing Wang, Yun Zhou, Tian-Hua Wei, Xin Xue, Wei-Chen Dai, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Multiple myeloma (MM), a cancer of plasma cells, is the second most common hematological malignancy which is characterized by aberrant plasma cells infiltration in the bone marrow and complex heterogeneous cytogenetic abnormalities. Over the past two decades, novel treatment strategies such as proteasome inhibitors, immunomodulators, and monoclonal antibodies have significantly improved the relative survival rate of MM patients. However, the development of drug resistance results in the majority of MM patients suffering from relapse, limited treatment options and uncontrolled disease progression after relapse...
April 20, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38648685/celiac-disease-hope-for-new-treatments-beyond-a-gluten-free-diet
#35
REVIEW
Maxim D'heedene, Tim Vanuytsel, Lucas Wauters
BACKGROUND & AIMS: Celiac disease (CD) is a chronic inflammatory disease of the small intestine induced and maintained by gluten ingestion in susceptible individuals. Current treatment consists of strict adherence to a lifelong gluten-free diet (GFD) which is considered safe and effective in the large majority of patients. However, since adherence to a GFD is difficult and has a negative impact on quality of life, an increasing interest in other treatment options has emerged. Moreover, in some individuals a GFD is not sufficiently effective, necessitating alternative treatments...
April 15, 2024: Clinical Nutrition
https://read.qxmd.com/read/38648666/best-practice-for-therapeutic-drug-monitoring-of-infliximab-position-statement-from-the-international-association-of-therapeutic-drug-monitoring-and-clinical-toxicology
#36
JOURNAL ARTICLE
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian G Wicha, Gertjan Wolbink, Jo Lambert, Séverine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
BACKGROUND: Infliximab, an anti-tumor necrosis factor monoclonal antibody, has revolutionized the pharmacological management of immune-mediated inflammatory diseases (IMIDs). This position statement critically reviews and examines existing data on therapeutic drug monitoring (TDM) of infliximab in patients with IMIDs. It provides a practical guide on implementing TDM in current clinical practices and outlines priority areas for future research. METHODS: The endorsing TDM of Biologics and Pharmacometrics Committees of the International Association of TDM and Clinical Toxicology collaborated to create this position statement...
April 17, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38648267/meningeal-lymphatics-in-central-nervous-system-diseases
#37
REVIEW
Andrea Francesca M Salvador, Nora Abduljawad, Jonathan Kipnis
Since its recent discovery, the meningeal lymphatic system has reshaped our understanding of central nervous system (CNS) fluid exchange, waste clearance, immune cell trafficking, and immune privilege. Meningeal lymphatics have also been demonstrated to functionally modify the outcome of neurological disorders and their responses to treatment, including brain tumors, inflammatory diseases such as multiple sclerosis, CNS injuries, and neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. In this review, we discuss recent evidence of the contribution of meningeal lymphatics to neurological diseases, as well as the available experimental methods for manipulating meningeal lymphatics in these conditions...
April 22, 2024: Annual Review of Neuroscience
https://read.qxmd.com/read/38648107/targeting-the-tgf-%C3%AE-signaling-pathway-an-updated-patent-review-2021-present
#38
REVIEW
Wenhao Guo, Hanwen Liu, Yong Yan, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
INTRODUCTION: The TGF-β signaling pathway is a complex network that plays a crucial role in regulating essential biological functions and is implicated in the onset and progression of multiple diseases. This review highlights the recent advancements in developing inhibitors targeting the TGF-β signaling pathway and their potential therapeutic applications in various diseases. AREA COVERED: The review discusses patents on active molecules related to the TGF-β signaling pathway, focusing on three strategies: TGF-β activity inhibition, blocking TGF-β receptor binding, and disruption of the signaling pathway using small molecule inhibitors...
April 22, 2024: Expert Opinion on Therapeutic Patents
https://read.qxmd.com/read/38648042/associations-between-surrogate-markers-and-clinical-outcomes-for-nononcologic-chronic-disease-treatments
#39
JOURNAL ARTICLE
Joshua D Wallach, Samuel Yoon, Harry Doernberg, Laura R Glick, Oriana Ciani, Rod S Taylor, Maryam Mooghali, Reshma Ramachandran, Joseph S Ross
IMPORTANCE: Surrogate markers are increasingly used as primary end points in clinical trials supporting drug approvals. OBJECTIVE: To systematically summarize the evidence from meta-analyses, systematic reviews and meta-analyses, and pooled analyses (hereafter, meta-analyses) of clinical trials examining the strength of association between treatment effects measured using surrogate markers and clinical outcomes in nononcologic chronic diseases. DATA SOURCES: The Food and Drug Administration (FDA) Adult Surrogate Endpoint Table and MEDLINE from inception to March 19, 2023...
April 22, 2024: JAMA
https://read.qxmd.com/read/38647060/characteristics-of-polish-travellers-admitted-at-the-university-centre-of-maritime-and-tropical-medicine-in-poland-2023
#40
JOURNAL ARTICLE
Krzysztof Korzeniewski
BACKGROUND: After COVID-19 restrictions were lifted, people started to travel again. Each year, thousands of Poles travel internationally, and many travel to tropical or subtropical destinations in Asia, Africa or South America. The aim of this article was to describe the characteristics of Polish travellers based on the information from a retrospective 12-month review of the medical records of Polish patients seeking pre-travel advice at the largest diagnostic and treatment travel medicine centre in Poland in 2023...
2024: International Maritime Health
keyword
keyword
8932
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.